Skip to main content
. 2022 Jan 28;10(1):80–92. doi: 10.1002/ueg2.12194

TABLE 2.

Lesion's characteristics according to histology

Histology data
Other V3 V4 V5–pT1a V5–pT1b ≥pT2 Adenocarcinoma Adenocarcinoma
(LGD) (pTis) (≤1,000 µm) (>1,000 µm) ≥V4.4 ≥V5
Characterization data, n (%)
Type
Protruding lesion 20 (23.5) 51 (60) 5 (5.9) 7 (8.2) 2 (2.3) 34 (40) 14 (16.5)
G ‐LST 153 (34.8) 253 (57.5) 15 (3.4) 17 (3.9) 2 (0.5) 134 (30.5) 34 (7.7)
GH‐LST 91 (52.9) 77 (44.8) 1 (0.6) 1 (0.6) 19 (11) 2 (1.2)
GN‐LST 61 (22.7) 174 (64.9) 15 (5.6) 16 (6) 2 (0.8) 115 (42.9) 32 (11.9)
NG‐LST 43 (34.1) 72 (57.1) 9 (7.1) 2 (1.6) 28 (22.2) 11 (8.7)
Flat 30 (38) 45 (59.5) 3 (3.8) 1 (1.3) 15 (19) 4 (5.1)
Pseudo‐depressed 13 (27.7) 27 (57.5 6 (12.8) 5 (10.6) 13 (27.7) 7 (14.9)
Macronodule >1cm  82 (23.2) 227 (64.1) 18 (5.1) 23 (6.5) 4 (1,2) 150 (42,4) 45 (12,7)
Depressed area (0‐IIc) 24 (26.1) 52 (56.5) 9 (9.8) 7 (7.6) 36 (39.1) 16 (17.4)
SANO IIIA area 56 (21.1) 170 (64.2) 19 (7.2) 18 (6.8) 2 (0.8) 111 (41.9) 39 (14.7)
CONECCT IIA 80 (54.8) 65 (44.5) 10 (6.8)
CONECCT IIC 137 (27.2) 313 (62.1) 29 (5.8) 26 (5.2) 4 (0.8) 187 (36.9) 59 (11.7)
ALL LESION n/663, (%) 12 (1.8) 216 (32.6) 376 (56.7) 29 (4.4) 26 (3.9) 4 (0.6) 196 (29.6) 59 (8.9)